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1 Abstract
2 Chlamydia trachomatis are obligate intracellular bacteria that undergo dynamic 
3 morphologic and physiologic conversions upon gaining access to a eukaryotic 
4 cell. These conversions likely require the detection of key environmental 
5 conditions and regulation of metabolic activity. Chlamydia encodes homologs to 
6 proteins in the Rsb phosphoregulatory partner-switch pathway, best described in 
7 Bacillus subtilis. ORF CT588 has strong sequence similarity to RsbU cytoplasmic 
8 phosphatase domain but also contains a unique periplasmic sensor domain that 
9 is expected to control phosphatase activity. A 1.7 Å crystal structure of the 
10 periplasmic domain of the RsbU protein from C. trachomatis (PDB 6MAB) 
11 displays close structural similarity to DctB from Vibrio and Sinorhizobium. DctB 
12 has been shown both structurally and functionally to specifically bind to the TCA 
13 cycle intermediate succinate. Surface plasmon resonance and differential 
14 scanning fluorimetry of TCA intermediates and potential metabolites from a 
15 virtual screen of RsbU revealed that alpha-ketoglutarate, malate, and 
16 oxaloacetate bound to the RsbU periplasmic domain. Substitutions in the putative 
17 binding site resulted in reduced binding capabilities. A RsbU-null mutant showed 
18 severe growth defects which could be restored through genetic complementation. 
19 Chemical inhibition of ATP synthesis by oxidative phosphorylation phenocopied 
20 the growth defect observed in the RsbU null strain.  Altogether, these data 
21 support a model with the Rsb system responding differentially to TCA cycle 
22 intermediates to regulate metabolism and key differentiation processes. 
23 Introduction
24 Bacteria possess the ability to sense changes in environmental conditions 
25 and adjust biologic activities through diverse regulatory components and 
26 mechanisms [1]. Often times these reactions are in responses to general 
27 environmental stresses as is the case with the Regulator of Sigma B or Rsb 
28 system. This phosphoregulatory partner switching system is found mainly in 
29 Firmicutes and is most thoroughly described in Bacillus subtilis [2]. A central 
30 regulatory component in this system is a phosphatase termed RsbU. Under 
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32 on an intermediate protein partner, RsbV. This allows another protein partner and 
33 kinase, RsbW, to ‘switch’ from association with sigma B to rephosphorylate 
34 RsbV. Ultimately, this enables the alternative sigma factor to freely diffuse and 
35 form an RNA holoenzyme polymerase, which activates the transcription of over a 
36 hundred genes that assist with the response to environmental stress [3-10]. 
37 While the Rsb system is typically associated with general stress responses in 
38 Firmicutes, it has also been associated with regulating diverse processes in other 
39 bacteria phyla including biofilm formation, type III secretion, and swarming 
40 motility [11, 12].
41 Chlamydia undergo dynamic morphologic and physiologic conversions 
42 upon gaining access to a eukaryotic cell. These conversions occur as Chlamydia 
43 grows and propagates through a phylum-defining biphasic developmental cycle. 
44 The initial phase of the chlamydial developmental cycle is conversion from an 
45 infectious, non-replicative and metabolically inert form known as an elementary 
46 body (EB) to a non-infectious, metabolically active and replicative form, known as 
47 a reticulate body (RB). This conversion occurs upon gaining access to the cell 
48 and establishing the intracellular vacuole termed the inclusion [13]. Many ATP 
49 requiring processes occur during the EB to RB conversion including protein 
50 secretion and de novo transcription and translational activity. RBs also need to 
51 acquire most macromolecules from the host cell, including glucose-6-phosphate, 
52 nucleotides, amino acids, lipids, and other metabolic precursors for growth and 
53 multiple rounds of replication [14]. The second phase is the asynchronous RB to 
54 EB conversion which occurs later in the developmental cycle through unknown 
55 signals and poorly understood mechanisms. This conversion also requires 
56 coordinated events that includes membrane remodeling and infectious capability 
57 preparation while metabolic processes, including transcription and translation, 
58 are silenced [15, 16]. Chlamydia also organize the escape from the infected host 
59 cell through either cell lysis or extruding vacuoles which enables the infection of 
60 new cells and possible a new host.
61 Chlamydia appear to acquire ATP from the host cell using ATP 
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63 oxidative phosphorylation processes. Interestingly, these processes appear to be 
64 functional at different developmental stages. ATP stored in EBs may allow for 
65 initial protein secretion and transcription and translation processes to occur until 
66 RB conversion. After the initial entry into the host cell, ATP translocases are 
67 utilized to obtain ATP from the host cell [17]. During RB replication and midcycle 
68 growth stage, Liang et al. (2018) demonstrated that Chlamydia can also generate 
69 ATP using a sodium-ion gradient to drive the ATP-synthase [17]. Critical for this 
70 process is the TCA cycle [17]. Chlamydia spp. lack three canonical TCA 
71 enzymes: citrate synthase (gltA), aconitase (acn), and isocitrate dehydrogenase 
72 (icd) [18, 19]. Due to the absence of these enzymes, Chlamydia possess a 
73 truncated TCA cycle that starts with alpha-ketoglutarate and ends with 
74 oxaloacetate that can then be shuttled to other metabolic pathways [14]. This 
75 truncated TCA cycle does enable the chlamydial RBs to generate NADH, which 
76 drives the sodium-dependent NADH dehydrogenase and, subsequently, ATP 
77 generation [17]. However, because of the incomplete TCA cycle, Chlamydia must 
78 scavenge dicarboxylate intermediates, such as glutarate and alpha-ketoglutarate, 
79 from the host cell [18-20]. Consequently, there are substantial interactions 
80 between the parasitic chlamydial cells and the infected host cell. The intimate 
81 association between the host and chlamydial metabolisms suggests that 
82 signaling pathways in Chlamydia responding to the host’s metabolic milieu play 
83 critical roles in development and pathogenesis. Despite the likely importance of 
84 these signals, much of the basic biology of these pathways remains poorly 
85 understood, including the signal for the EB-to-RB conversion, mechanisms for 
86 sensing environmental stimuli, and the differential regulation of ATP acquisition.
87 A partner-switching pathway with similarities to the Rsb regulatory 
88 pathway could be a primary mechanism for Chlamydia to sense environmental 
89 conditions and regulate metabolic activity [19]. The chlamydial genome encodes 
90 genes for the production of RsbU (CT588), RsbV1 (CT424), RsbV2 (CT765), and 
91 RsbW (CT549) proteins (Figure 1) [19]. However, there are distinct differences 
92 from the canonical Rsb system in B. subtilis. For one, chlamydial RsbU is a 
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94 domain attached to a cytoplasmic phosphatase domain (Figure 2) [21-23].  In 
95 contrast, RsbU in B. subtilis are strictly cytoplasmic and do not contain a sensor 
96 domain, only possessing a phosphatase domain. It is expected that the 
97 chlamydial RsbU sensor domain is critical for controlling the phosphatase activitiy 
98 and downstream regulatory processes. Chlamydial RsbU has been shown to de-
99 phosphorylate RsbV1 but not RsbV2 [22].  Importantly, multiple studies on the 
100 biologic and functional outcomes of the terminal component and kinase, RsbW, 
101 support binding and inhibiting the primary sigma factor, 66 [21-23]. The expected 
102 result of this activity would be a global shutdown of most transcription in 
103 Chlamydia.  
104 To discover the potential binding ligands and response regulatory role of 
105 the Rsb system in Chlamydia, a crystal structure of the RsbU periplasmic domain 
106 was determined. This structure was used to identify structurally similar proteins 
107 for putative function predictions as well as direct virtual and experimental ligand-
108 binding analyses. Growth phenotypes of RsbU null mutant strains and in the 
109 presence of chemical inhibitors of key ATP generating functions were evaluated.   
110 Together, these observations support that RsbU is binding to TCA cycle 





116 CT588 has a unique domain organization with conserved cytoplasmic RsbU 
117 phosphatase domain and an uncharacterized domain predicted to localize 
118 to the periplasm. CT588 is a 650-residue protein with a carboxyl-terminal 
119 domain (269-645) that has high sequence similarity to the RsbU superfamily 
120 phosphatases (Figure 2). This cytoplasmic domain contains HAMP (residues 
121 338-385) and PP2C serine phosphatase (residues 422-625) subdomains with 
122 Smart E-values of 4.35 x 10-5 and 3.09 x 10-72, respectively [24]. The HAMP and 
123 PP2C domains together comprise a conserved RsbU family domain (residues 
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125 domains function as linker regions in order to modulate the transduction between 
126 sensor and effector domains  [25]. This transduction can occur with cytosolic as 
127 well as membrane associated proteins [26]. PP2C domains are metal-dependent 
128 protein phosphatases (PPMs), which catalyze the dephosphorylation of either a 
129 serine or threonine residue [27]. 
130 BLAST search using the N-terminus of CT588 (1-315) revealed sequence 
131 similarity to proteins only encoded by Chlamydia; however, the predicted function 
132 of these orthologs were unknown. In contrast to other RsbU family members, 
133 CT588 has two transmembrane helices that flank residues 40 through 315, which 
134 implies that this domain is localized to the periplasm. Based on sequence 
135 similarities, it is expected that a periplasmic signal is transduced by the HAMP 
136 domain to regulate the PP2C phosphatase activity of CT588. However, while this 
137 domain organization of CT588 appears to be unique among bacteria, this protein 
138 is widely conserved among Chlamydiaceae family.
139 I-TASSER was used to model protein structures for the N-terminus RsbU 
140 [28]. Four structural models with relatively poor C-scores (range from -3.19 to -
141 3.84) were generated reflecting the absence of sequence similarity to PDB 
142 templates. These models predict two protein domains that are tethered to a 
143 single alpha helix, which extends the length of these domains (Figure S1).  Using 
144 these models, DALI searches of the Protein Data Base (PDB) were performed to 
145 identify potential structural homologs and associated functional information. This 
146 search revealed that the top matches (Z-score > 15; range 16-21) were all 
147 periplasmic-localized chemoreceptors with PAS-like domains attached to kinase 
148 or methyl-accepting chemotaxis-like domains by linker regions such as HAMP or 
149 HisKA domains from diverse bacteria (Table S1). Many of these I-TASSER 
150 model structural homologs also had identified ligands that include L-Arginine, C4 
151 dicarboxylates, and asparagine.
152
153 A 1.7 Å crystal structure of the RsbU periplasmic domain reveals similarity 
154 to periplasmic domains of dicarboxylate binding sensor proteins. A crystal 
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156 understand its function. A construct comprised of residues 45-313 (RsbU45-313) 
157 was recombinantly expressed and purified via affinity and size exclusion 
158 chromatography (Figure S2) and then used to screen for crystallization 
159 conditions which led to a 1.7 Å resolution crystal structure. 
160 RsbU45-313 adopts a mixed / fold with two similar PAS subdomains, each 
161 containing antiparallel -strands flanked by pairs of -helices (Figure 3). The 
162 proximal domain contains five long and two short (two residues) -strands and 
163 the distal domain is composed of five long and one short strand. The secondary 
164 structure elements for RsbU were calculated using DSSP [29].  Interestingly, the 
165 proximal and distal subdomains exhibit a high degree of structural similarity, 
166 reflected by a root mean square deviation (RMSD) value of 1.37 Å for 47 aligned 
167 C atoms (Z=7.73) [30, 31].  Additionally, the total accessible surface area of the 
168 subdomains, calculated using Areaimol via CCP4 [32], are similar with 5,021.6 Å 
169 for the distal (K114-D192) and 5,880.8 Å for the proximal subdomain (K210-
170 E302). Another interesting feature in the RsbU structure is that helix 1 is kinked 
171 near I54/T55 (Figure 3A, right panel). The angle between the two portions of this 
172 helix defined by Q45-S53 (1) and S56-T72 (1’) was found to be 36.7 as 
173 calculated using least-squares fitting of C atoms with Pymol. 
174 A DALI search comparing the RsbU45-313 crystal structure to all Protein 
175 Database (PDB) entries identified 14 non-redundant matches based on global 
176 structural similarity (Z-score >3.0; Table S2). The top two hits (Z-scores >15.5) 
177 were of the sensor domain from the histidine kinase DctB in Vibrio cholerae and 
178 Sinorhizobium meliloti (3BY9 and 3E4O, respectively), which binds to C4 di-
179 carboxylates (e.g. succinate). Looking broadly at the domain organization of 
180 RsbU from C. trachomatis compared to DctB in V. cholerae and S. meliloti, these 
181 proteins do appear similar in respect to the length of the periplasmic domain and 
182 the presence of two flanking transmembrane domains (Figure 2).  DctB is the 
183 membrane-bound sensor histidine kinase of a two-component system in 
184 Rhizobia, Vibrio, Escherichia, and other bacteria that sense extracellular C4-
185 dicarboxylates and reactively regulate their TCA cycle, one of the central 
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187 such as the TCA cycle intermediates malate and oxaloacetate. Once DctB 
188 senses its ligand, it phosphorylates and thereby activates the system’s response 
189 regulator DctD. Activated DctD then activates the expression of the 54-
190 dependent promoter of a C4-dicarboxylate:cation symporter, DctA [34-36]. 
191 Protein homologs of DctB, each of which are membrane bound kinases with 
192 periplasmic sensor domains, regulate a variety of responses beyond the TCA 
193 cycle as well [37-39].
194 Nine of the other matches from the DALI search were structures also co-
195 crystalized with ligands. These ligands range from amino acids and other 
196 carboxylates to nucleic acids. The remaining three protein matches have no 
197 ligands solved in their binding site. These 14 structural matches all are predicted 
198 to be membrane-bound proteins with PAS-like domains attached to kinase or 
199 methyl-accepting chemotaxis-like domains by linker regions such as HAMP or 
200 HisKA domains [24]. They regulate a variety of downstream processes such as 
201 chemotaxis, sporulation, and differential metabolite utilization [37, 38, 40-42]. 
202
203 Residues in the DctB binding pocket are not conserved in the putative 
204 binding pocket of RsbU45-313. As noted above, RsbU shares the highest degree 
205 of structural similarity with DctB. Superposition of DctB from V. cholera (3BY9) 
206 and S. meliloti (3E4O) with RsbU using Gesamt [43] yielded RMSD deviations of 
207 2.58 Å and 3.38 Å between C atoms for 205 and 196 residues aligned, 
208 respectively (Figure 4A and B). The RMSD deviation between C atoms for 
209 RsbU and apo DctB (3E4Q) is 3.45 Å (196 residues). Given the structural 
210 similarity with DctB, we set out to determine if a similar ligand binding site was 
211 present in RsbU.  DctB crystal structures from V. cholerae and S. meliloti have 
212 both been obtained with succinate bound in the ligand-binding pocket [34, 37]. 
213 Additionally, a structure of S. meliloti DctB has also been obtained as a complex 
214 with malonate. Although the structural similarity between RsbU45-313 and DctB 
215 from V. cholerae is greater, the availability of both apo and ligand-bound 
216 structures for DctB from S. meliloti allowed for a more in-depth comparison with 
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218 opened apo/C3-dicarboxylate (malonate) bound structure form, and a closed form 
219 when bound to a C4-dicarboxylate. The superposition of RsbU45-313 and apo and 
220 succinate-bound DctB is depicted in Figure 4C which highlights the ligand 
221 binding region. Specifically, when DctB binds to a C4-dicarboxylate, residues 
222 136-153 and 169-175 close around the ligand. For DctB the binding of succinate 
223 leads to a 2.2Å movement in residues 169-175 towards the ligand [34]. However, 
224 for RsbU these loop regions, which correspond to 132-153 and 159-167, are in a 
225 more open position suggesting that a conformational change may occur upon 
226 ligand binding. 
227 Despite the structural similarity, there is less than 20% sequence identity 
228 between RsbU and DctB sensor domains, particularly around the binding site as 
229 a BLAST search yielded no significant conservation of this region. Additionally, 
230 the ligand binding pocket of DctB contains a large patch of positively charged 
231 residues whereas RsbU has both positive and negatively charged regions 
232 (Figure 5). Relative to the superimposed structures, S161 and S163 of RsbU are 
233 similarly located relative to T171 and S173 of DctB. Additionally, Y142 of RsbU is 
234 positioned in a similar location relative to Y149 of DctB. The position of several 
235 charged residues within the binding site differ between DctB and RsbU, as 
236 highlighted in Figure 5. In RsbU there are no positively-charged residues in the 
237 corresponding location of R152 which interacts with succinate (Figure 5C). 
238 Instead there is a negatively-charged residue, E145, located in a similar region. 
239 Additionally, K197 of DctB, which is located on the middle -strand of the binding 
240 site -sheet, forms a salt bridge with the dicarboxylate ligand. While there is not a 
241 positively-charged residue in the corresponding location on the same -strand, 
242 K114 of RsbU is located on a neighboring -strand (Figure 5D). Overall, RsbU 
243 contains eight charged residues at or around the putative ligand binding site. 
244 These include negatively-charged E145, E115, E250 and positively-charged 
245 residues K114, R134, K140, and R248 lining the perimeter of the pocket. 
246
247 I-TASSER ab initio model of CT588 closely matches crystal structure. A 
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249 structure reveals a robust Z-score of 14.4 and RMSD of 4.0 Å (Figure S1). These 
250 data support that, despite extremely low sequence similarity between RsbU1-315 
251 and other proteins (maximum sequence similarity below 2% of the templates), I-
252 TASSER was effective in accurately modeling this protein. This ab initio protein 
253 modeling is particularly challenging, especially for proteins over 200 amino acids 
254 [44]. Additionally, comparison between DALI searches of I-TASSER and crystal 
255 structure highlights that more than half of the top 15 proteins with structural 
256 similarity are shared, including DctB (Table S1).
257
258 Virtual screen of human metabolite and chlamydial metabolite libraries 
259 yielded a small list of potential ligands for further testing. While the structure 
260 of RsbU is most similar to DctB, it shares the same fold as several other proteins 
261 that bind ligands other than dicarboxylates, such as amino acids, nitrogenous 
262 bases, and pyruvate (Table S3). Preliminary docking studies indicated that the 
263 C4-dicarboxylate succinate could interact with the positively charged sidechains 
264 of K140 and R134, however, these residues are located on the outer edge of the 
265 binding pocket, distal to where a tight-binding ligand would be expected to bind. 
266 In order to rationally select additional compounds for testing, a virtual screen was 
267 performed against compounds that are more likely to interact with by RsbU; 
268 namely human metabolites and metabolites associated with Chlamydia 
269 trachomatis. 
270 Over 100,000 compounds were computationally screened, and a final 
271 library of 26 potential ligands was selected for further testing. This library was 
272 composed of the top scoring compounds from the human and chlamydial 
273 metabolite libraries supplemented with TCA cycle intermediates or derivatives 
274 present in Chlamydia (Table S3). The addition of the TCA cycle intermediates or 
275 derivatives was included in order to fully investigate the possibility of the 
276 chlamydial RsbU protein binding to a molecule of similar structure and function 
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279 Binding studies support TCA cycle intermediates as RsbU ligands. Surface 
280 plasmon resonance (SPR) was selected as a method of screening the library of 
281 potential ligands for binding to the RsbU45-313 periplasmic domain due to its  
282 sensitivity and ability to determine estimates of binding kinetics [45]. In initial 
283 screening with the 26 potential ligands at 100 M and 1 mM concentration, 
284 binding was only observed for alpha-ketoglutarate, malate, and oxaloacetate 
285 (Figure S3). Subsequently, dose-dependent binding studies of these three 
286 potential ligands were performed. KD values were estimated to be 419  76 µM, 
287 459  91 µM, and 396  69 µM for alpha-ketoglutarate, malate, and oxaloacetate, 
288 respectively (Table 2). 
289 Docking with the alpha-ketoglutarate, malate, and oxaloacetate to RsbU 
290 identified specific residues at the putative binding site that could be coordinating 
291 ligand binding (Figure 6). Residues R134, Q137, and K140 were predicted to 
292 interact with alpha-ketoglutarate, malate, and oxaloacetate. R248 is also in 
293 proximity to the ligands. Based on these predicted residue interactions, individual 
294 alanine substitutions in the RsbU45-313 protein were created for R134, Q137, and 
295 K140, as well as a double-substitution with R134 and K140. SPR was performed 
296 with the alanine-substituted proteins compared to the wild-type protein. Table 2 
297 shows the average estimated KD values for the three TCA cycle intermediates 
298 with each of the protein variants. Both the signal-substitution variant, K140A, and 
299 the double-substitution variant, K140A/R134A, showed statistically-significant, 
300 albeit limited, decreases in binding affinity for the three TCA cycle intermediates. 
301 The R134A variant displayed a statistically-significant decrease in binding affinity 
302 for malate as well as lower binding capabilities to alpha-ketoglutarate (p-value 
303 0.082). Similarly, the Q137A single-substitution also had decreases in binding 
304 affinity for alpha-ketoglutarate and malate (p-value <0.1). 
305 Orthogonal analyses using differential scanning fluorimetry (DSF) was 
306 also performed with of potential ligands [46]. Significant stabilizing temperature 
307 shifts were observed with 5 mM and 10 mM additions of alpha-ketoglutarate and 
308 malate (Table S4). Oxaloacetate only showed a significant positive temperature 
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310 replicates. Additionally, a single trial of isothermal titration calorimetry (ITC) 
311 resulted in binding curves indicating stronger ligand binding with alpha-
312 ketoglutarate, malate, and oxaloacetate (KD values of 25.8 M, 22.0 M, 55.5 
313 M, respectively), but not succinate or malonate (data not shown). Overall, all 
314 three of these binding studies support the binding of the RsbU periplasmic 
315 domain to TCA cycle intermediates alpha-ketoglutarate, malate, and 
316 oxaloacetate.
317  
318 Nonsense mutation in rsbU gene suggests importance of Rsb 
319 pathway in chlamydial growth. Based on the three ligands and the potential for 
320 the regulation of ATP generation (oxidative phosphorylation), it was hypothesized 
321 that the absence of this sensing system could be detrimental to the growth of 
322 Chlamydia. To evaluate this hypothesis, a C. trachomatis L2 EMS mutant 
323 (CTL2M401) was obtained (Dr. R. Valdivia; Duke University) that contained a 
324 SNP causing a nonsense mutation at W284 in the ct588 gene coding for the 
325 RsbU protein [47, 48]. This nonsense mutation occurs towards the C-terminal 
326 end of the periplasmic domain resulting in a truncated protein lacking the 
327 cytoplasmic domain. Western blot analysis using antibodies raised against the 
328 periplasmic domain supported the absence of the full-length RsbU, as well as 
329 any lack of truncated product, in this mutant strain and is deemed a null mutant 
330 (RsbU*; Figure 7A). Growth of this RsbU* null mutant strain was assessed with 
331 DNA harvested at 0, 12, 24, 36, 48, and 72 hours post-infection. Genome copy 
332 numbers were compared between Chlamydia (secY) and host (rpp30) (Figure 
333 7B). Striking differences in the growth pattern of the mutant were observed 
334 compared to wild-type Chlamydia, with the mutant strain displaying minimal 
335 replication capabilities and generation of detectable infectious progeny (Figure 
336 7B and 7D).
337 Whole genome sequencing of this RsbU* mutant confirmed the truncating 
338 SNP in ct588 (rsbU). Thirty-two additional SNPs were also determined (Table 
339 S5). Of these SNPs, seven are silent mutations and four are in intergenic 
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341 respective coding regions with the majority predicted to have no obvious effect 
342 on protein function based on their likelihood to alter secondary structures or 
343 active domains as predicted by EMBOSS secondary structure prediction or 
344 BLASTp domain predictions. Two SNPs are predicted to alter secondary 
345 structures: a G105E mutation in CT259 and a Q204* mutation in CT163. The 
346 mutation in CT259 is predicted to form an alpha helix spanning E99 to F113 not 
347 predicted in the wild-type CT259 and has been associated with reduced 
348 phosphatase activity of the protein [49]. The most significant SNP, outside of 
349 rsbU*, is the additional truncation in CT163, a hypothetical protein with no 
350 conserved motifs. The CT163 protein is predicted to be a membrane protein with 
351 one transmembrane domain in C. trachomatis. The truncation stops translation 
352 one third of the way through the large putative extracellular domain, likely altering 
353 protein function. It is unclear what effect the truncation of this protein would have 
354 on the chlamydial developmental cycle and we cannot rule out the possibility that 
355 the SNP is contributing to the growth and morphological defects that have been 
356 determined for the RsbU* null mutant. 
357 In order to more confidently attribute the growth defect and phenotype to 
358 the RsbU disruption rather than the other SNPs induced by EMS mutagenesis, 
359 complementation efforts were pursued. However, because of the extremely poor 
360 growth of the RsbU* mutant, standard transformation with a wild-type rsbU gene 
361 on a vector plasmid proved unsuccessful. To overcome this limitation, lateral 
362 gene transfer was performed between C. trachomatis rsbU* (RifR) and another 
363 mutant strain that has a transposon (-lactamase) inserted in mutL (ct575::Tn 
364 bla), which is near the rsbU coding region (CT588).  After mixed infection and 
365 dual antibiotic selection, this was expected to encourage homologous 
366 recombination between the two genomes and restore rsbU coding region (Figure 
367 S4). This was expected to also leave the majority of SNPs including the ct163 
368 mutant truncation. Importantly, the transposon mutant strain (ct575::Tn bla) 
369 showed growth phenotypes matching wild-type C. trachomatis L2 strain (Figure 
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371 Sequencing of amplicons from various genomic regions revealed a cross-
372 over region in one of the resulting clones obtained following mixed infection and 
373 dual selection. Upon whole genome sequencing this complemented strain, the 
374 RsbU+ strain was revealed to be a mosaic between the RsbU* and wild-type 
375 genomes with a couple different regions of recombination apparent. In addition to 
376 a wild-type rsbU gene, the RsbU+ strain also has wild-type versions at 14 of the 
377 32 SNP loci, 11 of which are in coding regions (Figure S4). Because the 
378 complemented strain does not retain all of the RsbU* SNPS, it does leave open 
379 the possibility that one or more of those SNPs could be playing a role in the 
380 growth defect of the null mutant that is restored in the complemented strain. In 
381 particular, the SNP in the rpoD gene encoding 66 could effect on growth of the 
382 organism, however, the position of the SNP does not appear like it would have 
383 an effect on the structure of the protein, and is a region of the protein that does 
384 not appear to interact with the DNA binding [50]. Importantly, however, in the 
385 RsbU+ complemented strain, the non-sense mutation in the ct163 gene is 
386 maintained, meaning that any growth difference between the mutant and 
387 complemented strain is not due to this mutation. Growth curves were done with 
388 the parental transposon strain and the RsbU+ complemented strain, revealing 
389 that the RsbU+ strain showed a restoration in growth rate (Figure 7E).
390 We then hypothesized that the binding of TCA cycle intermediates to 
391 RsbU could indicate that the Rsb pathway is playing a regulatory role on TCA 
392 cycle activation in the chlamydial developmental cycle, leading to the poor growth 
393 of the RsbU* mutant. In order to test this hypothesis, we looked into chemical 
394 inhibitors targeting Chlamydia’s ability to produce ATP itself, as well as to steal 
395 ATP from the host cell using ATP translocases. 2-heptyl-4-hydrosyquinoline N-
396 oxide (HQNO) has been shown to selectively inhibit at low concentrations (1 M) 
397 the sodium-dependent NADH dehydrogenase that Chlamydia utilizes to produce 
398 the ion gradient that drives ATP synthesis by the chlamydial ATP synthase [17, 
399 51]. Alternatively, bongkrekic acid (BKA) has been shown to inhibit ATP 
400 translocases in Chlamydia, limiting the ability to utilize host ATP [52]. Growth 
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402 the addition of the chemical inhibitors (Figure 7C). BKA caused a decrease in the 
403 growth of wild-type Chlamydia that is statistically significant from wild-type (p-
404 value <0.05) after 24 hours, as well as from the RsbU* mutant after 24 hours. 
405 The addition of HQNO to a wild-type infection, however, was not statistically 
406 different from the RsbU* mutant growth at any time point. 
407 Additionally, progeny production was assessed for the RsbU* mutant 
408 strain, as well as wild-type infections with the BKA and HQNO chemical inhibitors 
409 (Figure 7D). This assay revealed that while there is a decrease in IFUs produced 
410 in the presence of BKA compared to the untreated WT infection, viable EBs are 
411 still being produced. However, in the RsbU* and WT + HQNO conditions, there is 
412 a decrease in the number of IFUs produced compared to the initial infection, 
413 suggesting that these cells are in the RB non-infectious form rather than 
414 converting to the infectious EB form. This is consistent with the growth curves in 
415 Figure 7C, where genome copies can be detected for these conditions, but RB-
416 to-EB conversion appear to stalled in the infection.
417 To further investigate the poor growth by the wild-type Chlamydia in the 
418 presence of the sodium-dependent NADH dehydrogenase inhibitor (HQNO) and 
419 translocase inhibitor (BKA) as well as by RsbU*, confocal microscopy was 
420 carried out to view L929 cells infected with wild-type Chlamydia or RsbU* with 
421 and without inhibitors at 24 and 72 hours (Figure 8). Image analysis revealed that 
422 the wild-type Chlamydia at 24 hours post-infection in the presence of HQNO 
423 inhibitor formed smaller inclusions and appear to contain fewer EBs (puncta), 
424 although chlamydial RB cells appear like wild-type. At 72 hours post-infection, 
425 Chlamydia infected in the presence of HQNO had inclusions that were grossly 
426 under-full compared to wild-type Chlamydia with no inhibitor. No obvious 
427 morphological abnormalities were apparent for wild-type Chlamydia in the 
428 presence of the BKA inhibitor. RsbU* was shown to have a severe growth defect 
429 with no defined development of an inclusion. Additionally, Chlamydia cells 
430 appear dispersed in the host cytosol at levels well under that seen by wild-type 
431 Chlamydia within inclusions at both 24 and 72 hours post-infection. RsbU* 
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433 Chlamydia cell forms. Addition of the HQNO and BKA inhibitors appeared to 
434 have no effect on levels of RsbU* Chlamydia or their dispersion within the host 
435 cell.
436 Overall, growth with HQNO causes a marked reduction in growth in wild-
437 type chlamydial infections, but does not have an additive effect on the growth 
438 defect observed in the RsbU* mutant. These observations support that the Rsb 
439 pathway in Chlamydia is linked to the ability of the bacteria to generate ATP via 
440 oxidative phosphorylation. 
441 Transcriptional analysis of TCA cycle-associated and constitutively 
442 active genes suggestive of Rsb pathway regulation of �66 activity. 66 is the 
443 primary sigma factor of only three sigma factors that Chlamydia sp. possess, and 
444 is responsible for transcription of the vast majority of genes throughout the 
445 developmental cycle. In order to further explore the proposed link between the 
446 Rsb pathway in Chlamydia to the regulation of 66 [22], transcript levels of 66-
447 transcribed genes were assessed for differential expression between the RsbU* 
448 mutant and WT L2 C. trachomatis (Figure 9). Genes chosen for this analysis 
449 included  TCA cycle associated genes (gltT, sucA, sdhB, mdhC, pckA), 
450 constitutively active “housekeeping” genes, (secY, rpoA, dnaK), and other genes 
451 associated with dicarboxylate processing or transport (xasA, ybhI, pdhB) [20]. All 
452 66-transcribed genes were observed to have lower transcript counts compared 
453 to wild-type, while the 28-transcribed gene, hctB, did not appear to be 
454 differentially expression between the two strains. These results suggest that 
455 when the Rsb pathway is disrupted, as in the RsbU* mutant strain, there is 
456 decrease in transcription of these genes under regulation of 66 activity.   
457
458 Discussion 
459 In order to characterize the role of the Rsb phosphoregulatory partner-switching 
460 pathway in Chlamydia, we focused on the structure and ligand-binding 
461 capabilities of the periplasmic domain of RsbU. A 1.7 Å crystal structure for the 
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463 proteins, leading to the identification of a putative binding pocket, and a possible 
464 association to the native ligand. 
465 SPR (Table 2 and Figure S3), DSF (Table S4), and ITC (data not shown) 
466 experiments suggest that alpha-ketoglutarate, malate, and oxaloacetate are 
467 binding to RsbU45-313. Dose-dependent SPR binding studies allowed for 
468 calculation of an estimated KD value of 419, 459, and 396 µM for alpha 
469 ketoglutarate, malate, and oxaloacetate, respectively. This is a relatively high KD 
470 value, indicative of weak binding; however, the concentrations of alpha-
471 ketoglutarate and malate used were those similar to physiological levels in the 
472 cell [53]. Similar proteins including Tlp3 from Campylobacter jejuni and PctA, 
473 PctB, and PctC from Psuedomonas aeruginosa have been shown to bind ligands 
474 at similar binding affinities [54, 55]. Alternatively, there are several factors that 
475 could be having an effect on the RsbU45-313 protein’s ability to bind to the ligand, 
476 including the need for dimerization for ligand binding and the lack of the 
477 cytoplasmic and transmembrane portions of the protein that my help to stabilize 
478 the protein binding [34, 35, 38, 56]. The KD values from the single ITC 
479 experiment were about a log lower than those values calculated from SPR, 
480 indicating tighter binding affinity. It is possible this discrepancy is due to the 
481 difference in the condition of the protein (free in solution with ITC compared to 
482 cross-linked to a surface with SPR). The KD values from the ITC experiment are 
483 closer to the KD determined for DctB binding to succinate, also determined by ITC 
484 [35].
485 The binding of multiple ligands allows for the possibility of differential 
486 responses upon binding. DctB has been shown to bind to both succinate and 
487 malonate, with a conformational change and loop closure of 2.2 Å with succinate, 
488 but not with malonate binding [34]. The aforementioned structurally similar Tlp3 
489 and Pct proteins also have been shown to bind to multiple ligands and have 
490 differential responses based on the identity of the ligand [54, 55].
491 Determining that RsbU is binding to TCA cycle intermediates lends itself to 
492 the question of what role this protein and its related pathway are playing in the 
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494 growth, an RsbU* mutant showed a severe deficit in growth compared to the 
495 wild-type strain supporting that the Rsb pathway plays a role in the normal 
496 pattern of chlamydial growth (Figure 7B) [48]. When complementation of the rsbU 
497 gene was accomplished through homologous recombination with the ct575::Tn 
498 strain, the growth pattern returned to wild-type-like levels (Figure 7E). 
499 Chlamydia has different ways that it can acquire energy. The presence of two 
500 ATP-ADP translocases allow for ATP uptake from the host cell appears to be the 
501 main source of energy when in the early stages of the developmental cycle, 
502 immediately after entry into the cell [57]. Chlamydia is then able to manufacture 
503 its own ATP utilizing a sodium-ion gradient to drive its ATP synthase activity 
504 during RB replication in midcycle time points as demonstrated by a recent 
505 publication by Liang et al. [17]. Wild-type chlamydial growth with HQNO, a 
506 sodium-dependent NADH dehydrogenase inhibitor, appears to mimic the growth 
507 pattern of the RsbU* mutation, potentially stalling the RB-to-EB conversion 
508 reducing the number of infectious progeny in the late stage of the developmental 
509 cycle as well (Figure 7C and 7D). While it possible that the loss of the NADH-
510 driven sodium gradient might also impact other processes that utilize the ion 
511 gradient, such as amino acid transport, when RsbU* was grown in the presence 
512 of HQNO, the growth pattern was similar to that of wild-type with HQNO. These 
513 data suggest that the inhibition of the sodium-dependent NADH dehydrogenase 
514 in the RsbU* strain does not have an additive effect on the growth defect, and 
515 that the Rsb pathway may be playing a role in Chlamydia’s production of ATP 
516 through oxidative phosphorylation. 
517 The dynamic energy utilization could account for the non-lethality of the 
518 RsbU* mutation. If Chlamydia is able to actively scavenge ATP and other 
519 metabolites from the host in its early developmental cycle, then there is the 
520 possibility of replication as well, albeit much more slowly. Moreover, there is the 
521 possibility for redundant pathways for activation of metabolic and replicative 
522 machinery. A second antagonist to the RsbW protein, RsbV2 (CT765), is also 
523 present in Chlamydia. Previous studies have shown that RsbU only 
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525 has a bias towards RsbV1 [22, 23]. This duality of RsbW antagonists could 
526 potentially mean that there is a secondary signal that has a similar, but possibly 
527 lesser effect on the repression of RsbW inhibition of the downstream target 
528 protein, and thus why the RsbU signaling disruption is not lethal. 
529 The target protein(s) for RsbW in Chlamydia is debatable. Several studies 
530 have investigated the potential protein interaction partners of RsbW in order to 
531 identify its target protein. Based on the Rsb system in B. subtilis, the target is 
532 presumed to be a sigma factor, for which Chlamydia has only three [9]. However, 
533 conflicting results have been observed in interaction studies with the primary 
534 chlamydial sigma factor,  66, in addition to the alternative sigma factors, 28 and 
535 54. Douglas and Hatch demonstrated that RsbW pulled down with 28 in vitro, 
536 while Hua and colleagues found that RsbW did not interact with any of the 
537 chlamydial sigma factors using a yeast two-hybrid system and an in vitro 28-
538 dependent transcription assay [21, 23]. Most recently, Thompson et al. found 
539 using a bacterial two-hybrid system, and validated using surface plasmon 
540 resonance experiments, that RsbW binds 66, but not 54 or 28 [22]. All this data 
541 combined has led to some uncertainty for any one sigma factor as the target 
542 protein, and the possibility for a non-sigma factor target has yet to be fully 
543 investigated. While the Rsb pathway described in B. subtilis and other gram-
544 positive bacteria regulates an alternative sigma factor, it is also worth considering 
545 that this pathway in Chlamydia may not be regulating such transcriptional 
546 machinery. In Bordetella, an RsbU homolog has been shown to be an important 
547 regulator of type three effector protein secretion without affecting transcription 
548 [11, 58]. Further efforts are being made to more definitively determine the target 
549 protein of the Rsb pathway and its specific role in the chlamydial developmental 
550 cycle; however, in this study, differential expression of 66-transcribed genes, 
551 TCA cycle-associated and otherwise, was also assessed (Figure 9). Of the 
552 genes selected for transcriptional analysis, all 66-transcribed genes appear to be 
553 down-regulated in the RsbU* mutant compared to WT L2 C. trachomatis, in 
554 contrast to 28-transcribed hctB [59]. This differential expression pattern between 
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556 disruption in the Rsb pathway and a decrease in 66-transcribed gene transcript 
557 levels. 
558 If the Rsb pathway regulates 66, as the most recent publication and this 
559 study suggests [22], the binding of alpha-ketoglutarate seems rational. 
560 Chlamydia is known to obtain alpha-ketoglutarate from the host cell as means for 
561 fueling its truncated TCA cycle to produce ATP through oxidative phosphorylation 
562 [20]. The presence of a pool of alpha-ketoglutarate that Chlamydia can access 
563 could be an indicator that the bacteria is inside of the host cell and in a favorable 
564 environment for replication, and thus the activation of the primary sigma factor.  
565 The regulation of 66 by the Rsb pathway may also explain the difference in the 
566 morphology of the RsbU* mutant compared to the wild-type Chlamydia with the 
567 HQNO inhibitor. While the HQNO inhibitor in the wild-type infection does mimic 
568 the RsbU* growth pattern, the IFA imaging (Figure 8) is not an exact phenocopy. 
569 There is still an obvious inclusion present in the wild-type infection in the 
570 presence of HQNO, although the amount of Chlamydia is clearly less, compared 
571 to the RsbU* mutant which does not appear to be inside of an inclusion, but 
572 instead clustered together in the host cell cytoplasm. The wild-type infection in 
573 this case would still have the ability to activate 66, while the RsbU* would have 
574 66 repression, thus having a larger pleiotropic effect and be diminished in its 
575 ability to transcribe genes for the establishment and maintenance of the 
576 inclusion, TCA cycle enzymes, and effective growth and replication of the 
577 organism. Liang et al. were also able to show similar growth phenotype when 
578 wild-type Chlamydia is in the presence of monensin, a Na+/H+ exchanger that 
579 dissociates the Na+ ion gradient driving the chlamydial ATP synthase [17].  
580 The idea of dynamic energy utility also leads to our proposed model of how 
581 the Rsb partner-switching pathway is playing a role in the Chlamydia 
582 developmental cycle (Figure 10). When an EB enters the host cell it comes in 
583 contact with an increased level of alpha-ketoglutarate, which binds to the RsbU 
584 periplasmic domain. In the current model, upon binding to alpha-ketoglutarate, 
585 the cytoplasmic effector domain of RsbU performs its phosphatase activity on 
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587 RsbV1 protein. That target protein then affects the activation of the TCA cycle in 
588 Chlamydia. This effect could be indirect, being a sigma factor, such as 66, or 
589 through the other transcriptional regulators or machinery that lead to the 
590 expression of other proteins involved in the TCA cycle; or direct, through 
591 activation of transport proteins for TCA cycle substrates or enzymes in the TCA 
592 cycle itself. Then when levels of alpha-ketoglutarate are waning, potentially 
593 towards the end of the developmental cycle, RsbU is no longer bound and the 
594 target protein is again inhibited by RsbW. Interestingly, temperature-sensitive 
595 mutants generated by Brothwell et al. for both sodTi (the putative dicarboxylate 
596 transporter) and gltT (the putative glutamate transporter) support that acquisition 
597 of alpha-ketoglutarate is important for chlamydial growth [60]. In addition, the 
598 levels of malate and/or oxaloacetate in the periplasm could act as an inhibitor for 
599 RsbU signaling. Malate or oxaloacetate could build up in the periplasm as it is 
600 transported out of the chlamydial cytoplasm by transporter proteins such as 
601 SodTi [61]. The phosphoenolpyruvate carboxylkinase (Pck) enzyme catalyzing 
602 the conversion of oxaloacetate to phosphoenolpyruvate has been shown to be 
603 differentially regulated as a mid-late stage gene, possibly leading to more malate 
604 and oxaloacetate being present in the cytoplasm to be exported into the 
605 periplasm by SodTi in exchange for alpha-ketoglutarate [62, 63]. Additionally, 
606 malate converted to oxaloacetate can also be used to synthesize meso-
607 diaminopimelate (mDAP), a crosslinker in the A1-type peptidoglycan Chlamydia 
608 synthesizes during growth [64, 65]. Peptidoglycan is only needed during growth 
609 of the Chlamydia cell [64, 66], and therefore a buildup of malate could occur as 
610 the cell ceases growth in preparation for the conversion to the EB form. 
611 Aspects of the Rsb phosphoregulatory partner-switching pathway still remain 
612 to be explored. While the transcriptional analysis supports the hypothesis that the 
613 target protein of the pathway could be 66, it does leave open the possibility of 
614 RsbW binding to a secondary transcriptional regulator. A phosphoproteomic 
615 analysis done in Chlamydia caviae showed that phosphorylated RsbV1 and 
616 RsbV2 can be detected in EBs, but not in RBs, rather than the other way around; 















This article is protected by copyright. All rights reserved
618 and RsbW, and the mechanism of which these proteins communicate [67]. 
619 Furthermore, the true response of RsbU to binding either alpha-ketoglutarate, 
620 malate, or oxaloacetate; whether they are activating or inhibiting to the 
621 phosphatase activity of the RsbU cytoplasmic domain, still remains to be fully 
622 examined. 
623 In this study, we were able to solve a 1.7Å crystal structure for the periplasmic 
624 domain of the chlamydial RsbU protein and utilize structural similarities to a 
625 dicarboxylate-binding protein to determine alpha-ketoglutarate, malate, and 
626 oxaloacetate as binding ligands. Moreover, an RsbU-null mutant was utilized to 
627 show the importance of the Rsb pathway in normal chlamydial growth. Finally, 
628 we proposed a working model for how this pathway may be sensing the 
629 aforementioned ligands to regulate the TCA cycle. 
630
631 Materials and Methods
632 Overexpression and purification of recombinant RsbU45-313. A fragment of 
633 ctl0851 encoding residues 45 through 313 of the open reading frame was 
634 amplified via polymerase chain reaction (PCR) from C. trachomatis L2 434/Bu 
635 (AM884176) genomic DNA. ctl0851 is homologous and 99% identical to CT588 
636 (RsbU) from C. trachomatis D/UW-3. This fragment was inserted into the pTBSG 
637 vector in frame and immediately downstream of a sequence encoding an N-
638 terminal hexahistidine tag and TEV protease recognition site. After confirming 
639 sequence accuracy, this vector was transformed into BL21 (DE3) E. coli 
640 competent cells, which were then grown at 37C (200 rpm) in Terrific Broth 
641 supplemented with 100 g/mL Carbenicillin to an OD600 of 0.8. Overnight protein 
642 expression (15C, 200 rpm) was induced at this optical density with the addition 
643 of IPTG (isopropyl 1-thio--D-galactopyranoside) to a final concentration of 1mM. 
644 Following E. coli collection by centrifugation (10,000g; 15 minutes), cells were 
645 resuspended in lysis buffer [20 mM Tris pH 8.0, 500 mM NaCl, 10 mM imidazole, 
646 1 mM phenylmethane sulfonyl fluoride (PMSF), and 1000U benzonase 
647 endonuclease (EMD Millipore) per liter of Terrific broth culture] and lysed by 
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649 clarified through a 0.45 m filter and purified on a gravity flow column containing 
650 3 mL of HisPur Cobalt Resin (ThermoFisher) per liter of Terrific Broth culture. 
651 Following washes with 5 column volumes (CVs) of lysis buffer and then 3 CVs of 
652 wash buffer (20 mM Tris pH 8.0, 500 mM NaCl, and 50 mM imidazole), 
653 immobilized His6-RsbU45-313 was eluted with 3 CVs of elution buffer ( 20 mM Tris 
654 pH 8.0, 500 mM NaCl, and 500 mM imidazole). The eluate was buffer exchanged 
655 into Buffer A (20 mM Tris pH 8.0, 500 mM NaCl, and 10 mM imidazole) on a 
656 HiPrep 26/10 Desalting column (GE Healthcare) and then incubated overnight at 
657 4C with 5 mM dithiothreitol (DTT) and recombinant polyhistidine-tagged TEV 
658 protease for His6-tag removal. Recombinant TEV protease and cleaved His6-tag 
659 were then removed from this mixture via flow over a 5 mL HisTrap HP column 
660 (GE Healthcare). Following buffer exchange into Buffer X (10 mM Tris pH 7.5, 50 
661 mM NaCl, and 1mM DTT) as described above, the sample was concentrated to a 
662 volume of 1.5 mL with an Amicon-15, Ultracel-10 centrifugal filter (EMD 
663 Millipore). Final purification was achieved via size exclusion chromatography 
664 using a flow rate of 0.2 mL/minute on a HiPrep 16/60 Sephacryl S-200 HR 
665 column (GE Healthcare). Collected fractions containing RsbU45-313 were 
666 concentrated to 15.9 mg/mL (by Bradford assay) via ultracentrifugation and 
667 stored at 4C until further use.  
668
669 Crystallization and data collection. All crystallization screening was conducted 
670 in Compact 300 (Rigaku Reagents) sitting drop vapor diffusion plates at 18C 
671 using equal volumes of protein solution and crystallization solution equilibrated 
672 against 75 L of the latter. Prismatic crystals grew within one day and continued 
673 to grow for approximately one week from Wizard 1-2 screen (Rigaku Reagents) 
674 condition E10 (1M ammonium phosphate dibasic, 100 mM Tris pH 8.5) and the 
675 Crystal Screen HT (Hampton Research) condition D5 [20% (w/v) PEG 4000, 
676 10% (v/v) 2-propanol, 100 mM Hepes pH7.5]. A heavy atom derivative was 
677 prepared by soaking a crystal obtained from Wizard 1-2 condition E10 for 22 
678 hours in crystallant containing 5 mM K2PtCl4. Native and heavy atom-soaked 
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680 ethylene glycol before flash freezing in liquid nitrogen. Data were collected at the 
681 Advanced Photon Source IMCA-CAT beamline 17-ID using a Dectris Pilatus 6M 
682 pixel array detector. 
683
684 Structure solution and refinement. Intensities were integrated using XDS via 
685 Autoproc, and the Laue class analysis and data scaling were performed with 
686 Aimless [29, 68, 69]. The highest probability Laue class was 4/m, for either space 
687 group I4 or I41. The Matthew’s coefficient (Vm) and solvent content were 
688 estimated to be Vm = 2.3/47% solvent for 1 molecule in the asymmetric unit [70]. 
689 Data for phasing were collected using the platinum-soaked crystals, at the 
690 absorption edge  = 1.0716 Å (11.570 keV) as determined from an X-ray 
691 fluorescence scan. Integrated defraction data from two crystals were scaled 
692 together with Aimless in order to increase the multiplicity. Structure solution was 
693 conducted using the SAD method with Autosolve via the Phenix interface, which 
694 yielded a figure of merit of 0.23 and a Bayes-CC of 0.299 [71]. The Autobuild 
695 step of Autosolve produced a model containing 188 of the possible 272 residues 
696 which converged at R= 0.35, Rfree = 0.44 following refinement. Crystals of native 
697 RsbU obtained from the Crystal Screen HT condition D5 yielded the highest 
698 resolution diffraction (1.7 Å) and were used from this point forward. The resulting 
699 model from Autosolve was used for molecular replacement with Phaser against a 
700 native RsbU data set and the top solution was obtained in the space group I4 
701 (TFZ = 45.8, LLG = 1,836) [72]. The model was further improved by automated 
702 model building using Arp/wARP and subsequent rounds of structure refinement 
703 and manual model building were carried out using Phenix and Coot [73, 74]. 
704 Residues P162, L163 and R313 were not modeled due to inadequate electron 
705 density. TLS refinement was incorporated in later rounds to model anisotropic 
706 atomic displacement parameters [75, 76]. Structure validation was conducted 
707 with Molprobity, and relevant crystallographic data are provided in Table 1 [77]. 
708 Coordinates and structure factors for RsbU were deposited to the Worldwide 
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711 Structural alignments and superimposition. Structures of DctB were obtained 
712 from the PDB. Apo DctB (3E4Q), Malonate-bound DctB (3E4P), and apo RsbU 
713 were aligned to beta sheet residues (120-198) of succinate-bound DctB (3E4O) 
714 using the Combinatorial Extension alignment method [78].  Alignments were 
715 performed using the NCBI Blast webserver [79]. Global alignments were 
716 performed using the Needleman-Wunch method, and local alignments were 
717 performed using BLAST. Proteins with the same fold were identified by 
718 performing a TM-alignment [80] of RsbU against the non-redundant structures 
719 from the PDB [28]. Proteins that had a TM-Score of at least 0.5, when normalized 
720 against RsbU, were considered to have the same fold [81, 82].
721
722 Virtual screen of human metabolite and chlamydial metabolite libraries. The 
723 human metabolites set of compounds was downloaded from the Human 
724 Metabolite Database and compounds with molecular weight greater than 300 
725 were discarded [83-85]. The Chlamydia metabolites set of compounds was 
726 downloaded from the Chlamydia trachomatis database in BioCyc [86]. Up to 250 
727 conformers were generated using Omega (version 2.5.1.4) by OpenEye (Santa 
728 Fe, NM) [87]. The receptor was prepared using APOPDB2RECEPTOR and 
729 compounds were docked into using FRED (version 3.2.0.2) at the “Standard” 
730 docking resolution (Santa Fe, NM), [88]. Docked models were refined using 
731 SZYBKI (version 1.9.0.3) (Sant Fe, NM). Compounds with docking scores above 
732 -6 (chosen based on the docking score of succinate), positive interaction 
733 energies, and minimized ligand poses that moved more than 1.5 Å were 
734 discarded. The remaining compounds were enriched with malate, malonate, 
735 alpha-ketoglutarate, succinate, -D-glucose, fumarate, glutamate, pyruvate, 3-
736 phosphoglyceric acid, oxaloacetate, and aldohexose stereoisomers. Compounds 
737 were prepared using LigPrep by Schrodinger using the default settings (New 
738 York, NY) to identify the physiologically relevant protonation states. The receptor 
739 was prepared using the protein preparation wizard in Schrodinger, which 
740 optimizes the hydrogen bonding and protonation state, followed by a constrained 
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742 (release 2017-3) by Schrodinger. Up to 5 docked poses were generated per 
743 compound, using extra precision (XP) settings [89-91]. Docked poses were then 
744 refined and free energies of binding were predicted using Prime MM-GBSA, 
745 allowing flexibility in residues within 8Å of the ligand [92, 93]. Compounds were 
746 selected based on the docking score, MM-GBSA predicted energy, predicted 
747 ligand efficiency, and visual inspection of the models. 
748 The docking models of oxaloacetate, alpha-ketoglutarate, and malate to 
749 RsbU were generated by docking using Glide XP followed by Prime MM-GBSA 
750 refinement, allowing flexibility in residues within 8Å of the ligand. 
751
752 Surface plasmon resonance. SPR runs were performed on a Biacore T200 (GE 
753 Healthcare Life Sciences) with cell culture grade Phosphate Buffered Saline 
754 (Corning). Purified RsbU45-313 protein in PBS was immobilized onto a Series S 
755 NTA or CM5 sensor chip (GE Healthcare Life Sciences). All ligands were 
756 dissolved in PBS and PBS only was used as a negative control. A flow cell with 
757 no protein bound was used as a reference cell for all runs. Ligands were injected 
758 over the chip for 30 seconds, with a 60 second dissociation period. Binding 
759 affinity was manually estimated using the steady state affinity equation: 
760 ���= �������+ �
761 where Req is the measured resonance units at steady state binding levels, C is 
762 the concentration of the ligand, and Rmax is the maximum binding capacity 
763 determined for each respective ligand assuming a 1:1 ratio of binding to protein.
764 Data was analyzed using Biacore T200 Software (version 3.0). 
765
766 Differential scanning fluorimetry (DSF). RsbU45-313 was purified as described 
767 above and buffer exchanged into PBS (Corning). DSF were performed with 
768 SyproOrange (Invitrogen) in 384-well plate (Roche) format [46]. The following 
769 potential ligands were tested: succinate, malonate, glutamate, alpha-
770 ketoglutarate, fumarate, oxaloacetate, malate, 2-phosphoglycerate, glucose, 
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772 dissolved in PBS. Compounds were added to each well, followed by DSF buffer 
773 HEPES-NaOH pH7.5 (100mM), and a 10X SyproOrange dye. Reliable baselines 
774 for Tm shifts were established using 10X SyproOrange and 10 M RsbU45-313. 
775 The mixture was heated from 20 to 85 C. Melting curves were analyzed on 
776 Roche Tm Analysis Software.  
777
778 Isothermal titration calorimetry (ITC). RsbU45-313 (30 M) was purified as 
779 described above and buffer exchanged into PBS (Corning). Alpha-ketoglutarate, 
780 malate, oxaloacetate, malonate, and succinate (Sigma-Aldrich) were dissolved in 
781 the same PBS used for the buffer exchange of the RsbU45-313 protein at a 
782 concentration of 30 mM. ITC was performed on a MicroCal PEAQ-ITC (Malvern 
783 Panalytical and analyzed using MicroCal ITC Analysis Software (version 1.21).
784
785 Growth Curves. An EMS mutant strain of Chlamydia trachomatis L2 was 
786 obtained from the Valdivia lab at the Duke University Medical Center [47, 48]. A 
787 confluent monolayer of L929 mouse fibroblast cells was infected with an MOI of 
788 0.5 mutant or wild-type chlamydial cells with centrifugation and using Hanks’ 
789 Balanced Salt Solution with calcium and magnesium (Corning). After 
790 centrifugation, the HBSS was removed from the cells and replaced with RPMI 
791 (Corning) supplemented with 5% FBS (Millipore), 10 g/mL gentamycin, and 1 
792 g/mL cycloheximide. For the growth curves with the addition of chemical 
793 inhibitors, the BKA and HQNO were added into the RPMI at the time of infection. 
794 HQNO was added at a final concentration of 1M. BKA was added at a final 
795 concentration of 0.25 M. The infected cells were incubated at 37C, 5% CO2 
796 until harvested. Total DNA was harvested from infected cells at 0, 12, 24, 36, 48, 
797 and 72 hours post infection. DNA was harvested by adding 200 l of 5mM DTT, 
798 200 L of Buffer AL from a Blood and Tissue Kit (Qiagen), and 20 l of 
799 Proteinase K (Qaigen) to each well and incubated at room temperature for 10 
800 minutes. Wells were then scrapped and washed twice with the lysate before 
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802 and then frozen until all time point samples were collected. The remainder of the 
803 DNA isolation was performed using the Blood and Tissue Kit (Qiagen).  
804 After DNA isolation was complete, the number of host genome copies and
805 Chlamydia genome copies was determined by Droplet Digital PCR (ddPCR) [94]. 
806 Chlamydia genome copies were assessed by the amplification of secY, and host 
807 cell genome copies were assessed by amplification of rpp30. Quantification of 
808 copy numbers was determined using Quantasoft software version 1.7 (Bio-Rad).
809
810 Progeny assay. L929 cells were infected with wild-type or RsbU* mutant strains 
811 of C. trachomatis L2 with BKA (0.25 M) and HQNO (1M) added at the time of 
812 infection when indicated. At 36 hpi, cells were either fixed and stained using 
813 MicroTrack C. trachomatis culture confirmation test (Syva Co., Palo Alto, CA), or 
814 lysed with water and passaged onto a new monolayer of host cells. An additional 
815 36 hours after passaging, the infections were fixed and stained. Fold changes 
816 were calculated by counting the IFUs of the infections after the first 36 hours and 
817 comparing to the IFU counts after the infections were passaged. 
818
819 Immunofluorescence microscopy. L929 cells were grown to confluency in an 
820 8-well ibiTreat µ-Slide (Ibidi, Martinsried, Germany) and were infected with 
821 respective wild-type C. trachomatis L2, RsbU* mutant, RsbU+ complemented 
822 strain, or ct575::Tn bla strain. Chemical inhibitors (HQNO and BKA) were added 
823 to the indicated conditions immediately after infection.  At 24 and 72 hpi, infected 
824 cells were fixed with 100% methanol for 10 minutes at room temperature. Cells 
825 were washed once with HBSS and again with PBS then stained using 180µl of 
826 the MicroTrack C. trachomatis culture confirmation test (Syva Co., Palo Alto, CA) 
827 diluted 1:40 in PBS 1 hour and 50 minutes at room temperature. 20µl of 1µM 4’, 
828 6-diamidino-2-phenylindole (DAPI) diluted 1:100 in PBS was then added to wells 
829 and allowed to stain for 10 minutes, room temperature in the dark. Stain was 
830 then removed, and the cells washed with PBS. A final overlay of Vectashield 
831 antifade mounting medium (Burlingame, CA) was added and slides were 
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833 confocal inverted microscope at 150X magnification and captured on an Andor 
834 Zyla 4.2 sCMOS camera (Belfast, Northern Ireland). Microscope and camera 
835 were operated using SlideBook 6 software (Intelligent Imaging Innovations, 
836 Denver, USA). Exposure time remained consistent for all fields captured, with 
837 exposure for DAPI at 2 seconds, OmpA 3 seconds, and cytoplasm 3 seconds. 
838 Seven Z-stack images at 0.3µm apart were taken per field imaged.  Images were 
839 processed in SlideBook 6 and a No Neighbors Deconvolution with a subtraction 
840 constant of 0.4 was applied to all images. Images represent a maximum 
841 projection over the Z axis of all 7 acquired stacks for each field shown.
842
843 Whole genome sequencing.  Chlamydial DNA was extracted from RsbU* EBs. 
844 Briefly, 200uL of renografin-purified EBs were pelleted, resuspended in RQ1 
845 DNase buffer, water and RQ1 Dnase, incubated and stopped as per 
846 manufacturer’s instructions (Promega, Madison, WI). 2uL DTT was added to the 
847 EBs and DNA was extracted using the Qiagen Blood and Tissue DNA Extraction 
848 Kit (Qiagen, catalog number 69506) with following steps that optimize for DNA 
849 sequencing. Libraries were generated using the NEBNext Ultra II DNA library 
850 Prep kit (New England Biolabs, catalog number E7645S). DNA was sequenced 
851 by the Illumina Nextseq MO-SR150bp. Over 91 million reads were generated 
852 with a mean quality score of 32.78. Approximately 3% of reads were mapped to 
853 the Chlamydia trachomatis L2/434 (NC_010287) parent genome through 
854 reference-guided assembly using the Geneious assembler with up to 5 iterations. 
855 Total average coverage for the RsbU* genome was 400x. Through direct 
856 comparison with the reference genome, 33 SNPs were evaluated, including the 
857 RsbU* truncation which was confirmed to be a monoclonal polymorphism as 
858 98.6% of reads at that site confirmed the SNP. For the 32 other SNPs discovered 
859 in the RsbU* genome, potential effects on secondary structure were analyzed 
860 using Geneious secondary structure predictions based on the EMBOSS 6.5.7 
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863 Generation of RsbU complemented mutant (RsbU+) by lateral gene 
864 transfer. A confluent layer of Vero monkey kidney cells in a T-75 cell culture 
865 flask was infected with 100µl of RsbU* lysate in 1X SPG buffer. Briefly, the 
866 monolayer was washed once with HBSS, and 10ml of HBSS was added to the 
867 culture flask along with RsbU* lysate. Cells were spun at 550XG for 30 minutes 
868 at room temperature. Infection material was aspirated from the flask and 15ml of 
869 RPMI containing 1µg/ml cyclohexamide was added to the flask. Infected cells 
870 were incubated at 37°C for 85 hours post-infection. RsbU* infected cells were 
871 then co-infected, as described above, with a C. trachomatis mutant containing a 
872 transposon insertion in ct575 (ct575::Tn bla). Co-infected cells were incubated 
873 another 48 hours at 37°C. Cells were then lysed by water lysis and transferred to 
874 Vero cell monolayers in a 24-well plate with each well containing variable 
875 concentrations of rifampicin and ampicillin to facilitate successful lateral gene 
876 transfer of the bla resistance marker of the ct575::Tn into the RsbU* mutant 
877 clone. After 24hpi, WT-like Chlamydia growth was identified by phase contrast 
878 microscopy in a well containing 0.01µg/ml rifampicin and 5 ug/ml ampicillin. After 
879 32hpi, cells in the well containing growth were lysed by water and the lysate then 
880 underwent two rounds of limiting dilution in a 96-well plate to isolate a clonal 
881 population of RsbU complemented mutant recombinants. Mutants with dual 
882 antibiotic resistance to rifampicin and ampicillin were evaluated by PCR 
883 amplification and sequencing for the genotype of the rsbU and ct163 genes, 
884 followed by the other SNPs present in the EMS mutant genome to determine 
885 where the area of homologous recombination occurred.
886
887 Transcriptional analysis. A confluent monolayer of L929 cells were infected 
888 with either WT L2 C. trachomatis or the RsbU* mutant strain at an MOI of 1. At 
889 24 hpi, the infections were harvested for RNA using TRIzol (Invitrogen). RNA 
890 was purified by phenol/chloroform extraction followed by DNase treatment with 
891 TURBO DNase (Invitrogen). A final purification step was performed using the 
892 RNeasy Mini Kit (Qiagen) before converting the RNA to cDNA using the High-
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894 was assessed using a no reverse transcriptase control reaction. After gDNA 
895 depletion has been confirmed for all RNA samples, transcript counts are 
896 quantified using ddPCR (Bio-Rad). gDNA taken from the infections was used to 
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1191 1. 2 The 
1193 current 
1194 model of the 
1195 Rsb 
1196 phospho-switching pathway in Chlamydia. RsbW binds and inhibits the 
1197 activity of a target protein (black box). However, when RsbV1 is 
1198 dephosphorylated, RsbW will release its target protein to act as a kinase to 
1199 phosphorylate RsbV1 (Hua, 2006; Thompson, 2015). RsbU acts as an antagonist 
1200 of RsbW by dephosphorylating RsbV1 in response to binding a ligand in the 





KD SD KD SD KD SD
WT RsbU45-313 419 76 459 91 396 69
R134A 526 84 601* 62 379 57
Q137A 548 112 666 233 459 96
K140A 597* 120 836* 54 569* 144
K140A/R134A 558* 68 741* 49 580* 97
SD = Standard deviation
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1201 periplasm (Thompson, 2015). Ultimately, the binding of the ligand to the RsbU 
1202 protein leads to the release of the target protein. 
1203
1204 Figure 2. Domain organization of RsbU from C. trachomatis and homologs 
1205 from other bacteria. RsbU from C. trachomatis bears sequence similarity to 
1206 RsbU from B. subtilis in the cytoplasmic domain, both containing PP2C domains. 
1207 RsbU in B. subtilis, however, does not contain any transmembrane helices, nor a 
1208 periplasmic portion. Structural comparison of the periplasmic portion of RsbU 
1209 reveals similarity to the periplasmic domain of DctB proteins in V. cholerae and 
1210 S. meliloti. Amino acids are numbered at the beginning and end of domains. TM 
1211 denotes transmembrane helices.  
1212
1213 Figure 3. Ribbon model of RsbU periplasmic domain (residues 43-313) 
1214 crystal structure (PDB 6MAB).  A) Tertiary structure showing helices (magenta) 
1215 and b-sheets (green). The middle and right panels are views rotated 90o and 
1216 180o about the vertical direction. The two regions of the kinked helix are denoted 
1217 as ⍺1 and ⍺ 1’.  B) Secondary structure annotation relative to the RsbU 
1218 sequence.
1219
1220 Figure 4. Superposition of RsbU (6MAB, magenta) with A) Apo (3E4Q, cyan) 
1221 and B) succinate-bound (3E4O, green) DctB structure. The succinate 
1222 molecule is rendered as spheres to highlight the ligand binding region. C) 
1223 Zoomed in view of the ligand binding pocket with succinate rendered as 
1224 cylinders. There are evident differences between RsbU and DctB, which is more 
1225 enclosed. However, structural comparison between the apo and succinate-bound 
1226 forms of DctB from S. meliloti reveal that the linker between strands 3 and 4 
1227 (residues 169-175) shift in distance of 2.2 Å towards the binding pocket when 
1228 succinate is bound, thereby facilitating pocket enclosure (Zhou et al).
1229
1230 Figure 5. Residues in the ligand binding pocket of DctB (3E4O) and putative 
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1232 Electrostatic surface for DctB and B) RsbU. C) Charged residues for DctB 
1233 showing hydrogen bond interactions with succinate (dashed lines). D) Charged 
1234 residues in the putative ligand binding pocket of RsbU. 
1235
1236 Figure 6. Ligand docking showing the predicted binding modes of A) 
1237 ketoglutarate, B) malate, and C) oxaloacetate in the binding pocket of 
1238 RsbU. All the ligands are rendered as gray cylinders. Interacting residues are 
1239 annotated in panel A.
1240
1241 Figure 7. The Rsb pathway affects normal growth of Chlamydia. (A) Western 
1242 blot of WT and RsbU* expression of RsbU protein at 24 hours post-infection. No 
1243 RsbU protein fragment is detected in the RsbU* mutant strain. MOMP is used as 
1244 a loading control.  (B) Chlamydia genome copy numbers (secY) were compared 
1245 to host cell genome copy numbers (rpp30) over 72 hours after the initial infection. 
1246 RsbU* appears to begin replicating around 72 hours post-infection (* p-value 
1247 <0.05 with student’s T-test). (C) Growth curves with chemical inhibitors, HQNO 
1248 and BKA, show significant differences between WT and WT +BKA after 24 hours, 
1249 as well as RsbU* and WT +BKA (p-value >0.05). With HQNO added, both WT 
1250 and RsbU* were not statistically different from RsbU* without any inhibitors. (D) 
1251 Progeny assay looking at the difference in IFUs produced after 36 hpi compared 
1252 to the IFUs in the initial infection. The decrease in IFUs produced by the RsbU* 
1253 strain, as well as WT treated with HQNO, suggest that the chlamydial cells are 
1254 largely in the RB form at this point in the infection rather than the EB form 
1255 capable of propagating the infection to new host cells. While all three 
1256 experimental conditions were significantly different from the WT untreated 
1257 condition (**p-value <0.001 with student’s T-test), the RsbU* mutant compared to 
1258 the HQNO treated infection shows no significant difference (p-value = 0.3). (E) 
1259 The RsbU+ recombinant strain, with WT RsbU expression but retaining the 
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1262 Figure 8. Immunofluorescent microscopy of Chlamydia with RsbU* 
1263 disruption and inhibitors of sodium-dependent NADH dehydrogenase and 
1264 ATP translocase. L929 cells infected with wild-type C. trachomatis or RsbU* 
1265 with and without the presence of inhibitor (HQNO or BKA) at 24 and 72 hours 
1266 post-infection. Blue: DAPI, nucleus; Red: Evan’s Blue, cytoplasm; Green: OmpA, 
1267 C. trachomatis organisms. Images were acquired by confocal microscopy using a 
1268 150X objective and are comprised of 7 compressed Z-stacks (maximum 
1269 projection) for each field.
1270
1271 Figure 9. Differential expression of TCA cycle-associated genes and other 
1272 sigma-66 transcribed genes in RsbU* mutant compared to WT L2 transcript 
1273 levels at 24 hpi. Genomic levels of DNA per infection were used to normalize 
1274 transcript counts. Sigma-28 transcribed gene, hctB, shows similar transcript 
1275 levels between the RsbU* mutant and WT L2, while those genes with �66 
1276 promoters all show significant decreases in the level of transcripts (*p-value 
1277 >0.05; **p-value >0.01 with student’s T-test). Genes selected for this analysis 
1278 included TCA cycle-associated genes (gltT, sucA, sdhB, mdhC, pckA), 
1279 constitutively active genes (secY, rpoA, dnaK), and other genes associated with 
1280 dicarboxylate processing or transport (xasA, ybhI, pdhB), all of which as �66-
1281 transcribed genes. 
1282
1283 Figure 10. Working model of the Rsb phospho-regulatory pathway 
1284 integrated with the truncated TCA cycle in Chlamydia. Alpha-ketoglutarate 
1285 binding to the periplasmic domain of RsbU, as could be the case when an EB 
1286 enters the host cell, leads to the activation of the phosphatase function of the 
1287 cytoplasmic domain. RsbW then releases its target protein (black box), allowing 
1288 for its normal function to be performed. That target protein then, either directly or 
1289 indirectly, activates the chlamydial TCA cycle, allowing for alpha-ketoglutarate to 
1290 be utilized. Chlamydia has been shown to be capable of creating its own ATP 
1291 during mid-cycle using a truncated TCA cycle to generate electron-carrying 
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1293 oxidoreductase (Na+-NQR) (Liang,2018). As malate builds up in the periplasm, 
1294 through the export by the SodTi protein (Weber, 1995), it acts as an inhibitor as 
1295 the concentration of alpha-ketoglutarate is depleted. The inhibition of the RsbU 
1296 protein or the depletion of alpha-ketoglutarate, potentially later in the 
1297 developmental cycle, could lead to a slowing of the TCA cycle as the Chlamydia 
1298 cells prepare to convert to the EB form. 
1299
1300 Supplemental Figures
1301 Figure S1. I-TASSER model of RsbU1-315 shares structural similarity to 
1302 periplasmic domain RsbU45-313 crystal structure. A) I-TASSER protein 
1303 structure model with residues 1 through 315 of C. trachomatis RsbU. B) Structure 
1304 overlay of RsbU45-313 crystal structure (magenta) and I-TASSER model (yellow). 
1305 Structure comparison has Z-score of 14.4 and a RMSD of 4.0 Å. 
1306
1307 Figure S2. SDS-PAGE gel showing purification of RsbU45-313. Lane 1, protein 
1308 marker; lane 2, lysate supernatant; lane 3, lysate pellet; lane 4, IMAC flow-
1309 through; lane 5, IMAC elution; lane 6, post-buffer exchange; lane 7, post-TEV 
1310 protease treatment; Lane 8, post-reverse nickel column; lane 9, SEC column 
1311 peak fraction. 
1312
1313 Figure S3. SPR dose-dependent binding curves. Alpha-ketoglutarate, malate, 
1314 and oxaloacetate show dose-dependent binding to RsbU45-313, while succinate 
1315 and malonate, the ligands found to bind to DctB, do not appear to be binding by 
1316 SPR.   
1317
1318 Figure S4. Chromosome schematic of cross between RsbU* EMS strain and 
1319 ct575::Tn strain to create the complemented RsbU+ strain that retains the 
1320 majority of the other SNPs induced by EMS mutagenesis. The ct575::Tn 
1321 strain contains a beta-lactamase resistance gene in the transposon, while the 
1322 RsbU* has a SNP in the rpoB gene that incurs rifampicin resistance. Dual 
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1324 that retained the RsbU* strain backbone but a wild-type version of the rsbU gene. 
1325 The red region on the RsbU+ chromosome represents the region of 
1326 recombination between the genomes confirmed by PCR of the SNPs present in 
1327 the RsbU* strain. In addition to the restoration of the rsbU gene, the RsbU+ strain 
1328 restores three other SNPs close to the position of the transposon: two in coding 
1329 regions for secY and polA; and one in an intergenic region (IGR).
1330
1331 Figure S5. Immunofluorescent microscopy of C. trachomatis ct575::Tn 
1332 parent strain and RsbU+ complemented strain.  At 24 and 72 hours post-
1333 infection, the RsbU+ complemented strain does not appear to be phenotypically 
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